Background: Chronic kidney disease (CKD) is a common disease in clinical practice and increases the risk for acute coronary syndrome, and there are little data about the relationship between the elevation of troponin T levels and morbidity and mortality outcomes in CKD patients. The aim of the work: is to estimate the appropriate highlysensitive troponin T average value in CKD patients who presented with acute coronary syndrome and its relation to the outcome. Patients and methods: The study included 60 patients who were sub-divided into two groups, First group: 30 patients with CKD and ACS as the study group, the second group: 30 patients with ACS without evidence of CKD as a control group. Measurement of the highly sensitive troponin T level after 1-3 hours of the onset of chest pain and calculation of the estimated glomerular filtration rate (eGFR) was done. Results: The mean levels of the highly sensitive troponin T levels were significantly higher in patients with CKD and ACS with p value less than 0.05 and there was significant statistical difference between mean of HS Trop T of patients with ACS and complications and those without (4.3 ± 1.1 vs. 2.1± 0.9 ng/ml; P= 0.03). Also mean of HS Trop T of patients with ACS that were died was significantly higher than those were improved (2.91± 0.6 vs. 3.1 ± 0.9; P = 0.02) Conclusion: There is direct negative correlation between the levels of highly sensitive troponin T and estimated glomerular filtration rate, but there is direct relation between the higher level of highly sensitive troponin T and mortality and morbidity rates in patients with ACS and CKD. The specificity of the highly sensitive troponin T decreases with the decreased estimated GFR in ACS and CKD patients resulting in higher level of highly sensitive troponin T required for the diagnosis of NSTE-ACS.
INTRODUCTION
Acute coronary syndrome (ACS) is one of the most common leading causes of death in emergency department around the world with an overall mortality rate >30 % (1) . Highly-sensitive troponin T (HScTnT) is a useful diagnostic tool for acute coronary syndrome (ACS). Highlysensitive troponin T is very specific to myocardial tissue, and a level of more than 0.014 ng/mL has specificity to acute myocardial infarction in normal renal function patients (2) . Although its high specificity for the diagnosis of acute coronary syndrome, It may be falsely elevated in many other pathological conditions as follows; Sepsis and Hypotension (3) , Noncardiac critically ill patients presenting to the emergency department (4) , Atrial fibrillation or other tachyarrhythmia's (5) , Acute pulmonary embolism (6) and Acute and chronic heart failure (7) . Chronic kidney disease (CKD) is a common disease in clinical practice and increases the risk for acute coronary syndrome and is also one of the false positive causes highly-sensitive troponin T (8) . Serum highly-sensitive troponin T levels in patients with renal dysfunction may be higher than the normal population, resulting in higher cutoff points for diagnosis of acute coronary syndrome (9) . Persistently elevated highly-sensitive troponin T is frequently observed among patients with chronic kidney disease (10) . The prevalence of increased highly-sensitive troponin T values among patients with chronic renal failure in the absence of clinically suspected ischemia may be as high as 53% (11) . In symptomatic patients with suspected acute coronary syndrome, elevation of Highly-sensitive troponin T is associated with adverse outcomes regardless of renal insufficiency, However, in patients with advanced renal failure, Highly-sensitive troponin T concentrations develop higher peaks and remain detectable for longer periods (12) . Highly-sensitive troponin T is commonly increased in asymptomatic patients with CKD, even when there is no suspected myocardial ischemia, and a level more than 0.04 is diagnostic for acute coronary syndrome in these patients (13) . Unfortunately, there are no approved protocols on the frequency and interval of blood sampling. Also, there are no available data about the relation between the elevation of troponin T levels and morbidity and mortality outcome in CKD population.
Aim of the work
This study aimed to find the appropriate Highlysensitive troponin T average value in CKD patients who presented with acute coronary syndrome diagnosed by history and examination, electrocardiogram, total CK, CK-MB and highly sensitive troponin T.
METHODS
The study included 60 patients at the Department of internal medicine, Assiut University Hospital, with CKD stages 2-5 (estimated GFR by Chronic Kidney Disease Epidemiology Collaboration formula and MDRD Equation less than 60 ml/min/1.73 m2). Patients were divided into two groups:
• First group: 30 patients with CKD and ACS as the study group. • Second group:30 patients with ACS without evidence of CKD as a control group.
Inclusion criteria:
All patients have evidence of acute coronary syndrome by history and examination, electrocardiogram, total CK, CK-MB and highly sensitive troponin T.
Half of the patients with evidence of CKD either Urine sediment abnormalities, Electrolyte and other abnormalities due to tubular disorders, Structural abnormalities detected by imaging (renal ultrasound), history of kidney transplantation or decreased GFR <60 ml/min/1.73 m2 (GFR categories G3a-G5)were included.
Exclusion criteria:
Patients with sepsis, hypotension or shock, critically ill patients, Acute Pulmonary Embolism, Acute and Chronic heart failure not related to ACS, cardio version, ablation and cardiac arrest and acute pericarditis were excluded. Also, patients who receive dialysis sessions before sampling and patients with evidence of Albuminuria without elevated serum creatinine (24 hours urinary proteins >30 mg/day; ACR >30 mg/g), were excluded. Each patient will be subjected to Full medical history and examination, Electrocardiogram (ECG), Echocardiography, Blood urea and serum creatinine, Urine analysis, Abdominal ultrasound, Total creatine phosphokinase (total CK) and CK-MB isomer and troponin T level after 1-3 hours of the onset of chest pain. Calculation of estimated glomerular filtration rate (eGFR) by MDRD equation and CKD epidemiology collaboration 2009 equation.
Statistical analysis:
The data were tested for normality using the Anderson-Darling test and for homogeneity variances prior to further statistical analysis. Categorical variables were described by number and percent (N,%), where continuous variables described by mean and standard deviation (Mean, SD Wallish for non-parametric data. A two-tailed p<0.05 was considered statistically significant. All analyses were performed with the IBMSPSS20.0software for ROC curve analysis.
RESULTS
This study aimed to find out the relation between Highly-sensitive troponin T average value in CKD patients and the estimated glomerular filtration rate in patients who presented with acute coronary syndrome (ACS) diagnosed by history and examination, electrocardiogram, total CK, CK-MB and highly sensitive troponin T and patients with CKD without evidence of ACS, as well as, the relation between the highly sensitive troponin T and the mortality and morbidity of complications following ACS. As mentioned before the study included two groups of subjects;
• Study group was formed of 30 patients with CKD and acute coronary syndrome • Control group was formed of 30 patients with acute coronary syndrome without CKD.
Part I: Demographic and Clinical Data of all Subjects
were included in our Study (Table 1) . There were no statistical differences between both groups; study and control group respecting demographic and clinical data where p value was more than 0.05. Mean duration of chest pain for the study group was 53.33 ± 14.23 minutes. Continuous data were expressed mean ± SD, and nominal data were expressed in the form of frequency (%). P value was considered of statistical significance if < 0.05.
Part II: Laboratory and imaging data of all Subjects were included in our Study ( Table 2 , Figure 1 ). This study results showed that eGFR calculated by CKD-EPI equation and MDRD were significantly higher in the study group compared to the control group with p value was less than 0.05. Mean of serum creatinine was significantly higher in the study group (239.37 ± 92.07 versus 214.27 ± 81.22 in control group)with p value was 0.02.
Respecting the renal imaging and albuminuria; there was no statistical difference between both groups (p= 0.61 and 0.57 respectively). Continuous data were expressed mean ± SD, and nominal data was expressed in the form of frequency (%). P value was considered of statistical significance if < 0.05. eGFR; estimated glomerular filtration rate, CKD-EPI; Chronic Kidney Disease Epidemiology Collaboration. 
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Data were expressed mean ± SD. P value was considered of statistical significance if < 0.05. Part IV: Characteristics of Patients with ACS and CKD (study group; n=30 patients). Table 7 showed characteristics of patients with ACS with CKD where the main line of therapy was anticoagulants (13 (43.3%)) patients. Nineteen patients (63.3%) had no complications, five (16.7%) patients with heart failure, three patients had arrhythmias (atrial fibrillation, ventricular tachycardia, 2nd degree heart block type I) and three patients (10%) were arrested and died. Twenty-seven patients (90%) were improved, but death occurred in three patients (10%); two with ventricular arrhythmia and one patient had complete heart block. Table 8 : showed that there was a significant statistical difference between the mean of HS Trop T of patients with ACS and complications and those without (4.3 ± 1.1 vs. 2.1± 0.9 ng/ml; P= 0.03). Also, mean of HS Trop T of patients with ACS that were died was significantly higher than those were improved (2.91± 0.6 vs. 3.1 ± 0.9; P = 0.02) ( Table 8) . Correlation between level of HS Trop T and eGFR in patients with ACS and CKD showed that there was moderate significant statistically inversely correlation between eGFR and HS Trop T (r = -0.5; P = 0.02) Figure ( 3). Data were expressed in the form of mean ±SD, and P value was considered significant if > 0.05
DISCUSSION
Acute coronary syndrome (ACS) is a common disease at emergency departments and has high morbidity and mortality (13) . In a similar study done by Yuwares Sittichanbuncha et al. 2015, They studied 210 patients with elevated highly sensitive troponin T and CAD. There were 132 patients (62.86%) had significant stenosis of coronary arteries by coronary angiograms. Highly sensitive Troponin T levels were significantly higher in all CKD patients with CAD. Also, levels of HScTnT were significantly higher in patients with high TIMI score. The highly sensitive Troponin T level of 0.041 ng/mL has sensitivity and specificity of 65.91% and 75.65%, respectively, for acute coronary syndrome (13) . Also in a similar study done by Van Lente F, et al.1999 , Who Found that the ability of cardiac troponin T and troponin I to predict risk for subsequent adverse outcomes including infarction, recurrent ischemia, bypass surgery, heart failure, stroke, death in patients presenting with suspected acute coronary syndromes is reduced in the presence of renal insufficiency, i.e, renal insufficiency is a false positive cause for elevated troponin T and I (14) . Chotivanawan T, et al. 2012 , have studied highlysensitive troponin-T levels in 89 patients with CKD stages 3-5 without evidence of ACS and found that 95th percentile of the total group was 0.139 ng/ml. 95th percentile for stage 3, 4 and 5 were 0.052, 0.136, 0.297 ng/ml, respectively. They found that CKDespecially stage 5 non hemodialysis group-decreases the specificity of highly sensitive troponin T in the detection of ACS in this morbid group (9) . Chenevier-Gobeaux, et al. (2013) studied 367 patients with low estimated glomerular filtration rate (eGFR) alter the diagnostic performance of high-sensitivity cardiac troponin T (HScTnT) in a prospective multicentric study. And found that older age, but not low eGFR, was an independent predictive factor of an elevated HScTnT at admission and adapted thresholds of highly sensitive troponin T are required for an accurate diagnosis of STEMI/NSTEMI in patients aged ≥70 and in those with low eGFR (10) . Our study results showed that eGFR calculated by CKD-EPI equation 2009 and MDRD formula was significantly lower in the study group compared to the control group with p value was less than 0.05. Mean of serum creatinine was significantly higher in the study group with p value was 0.02. Levels CK, CK-MB, Troponin I and Highly sensitive troponin T were significantly higher in patients with CKD and ACS with a p value less than 0.05 especially HScTnT (2.55 ± 0.33 in study group versus0.03 ± .0010 in control group). For cutoff point of 0.041 ng/ml, the highly sensitive Troponin T has 90% sensitivity and 52% specificity. There was a statistically significant difference between the mean of highly sensitive Troponin T of patients with ACS and complications and those without complications (4.3 ± 1.1 vs. 2.1± 0.9 ng/ml; respectively P= 0.03). Also, mean of HS Trop T of patients with ACS that were died was significantly higher than those were improved (2.91± 0.6 vs. 3.1 ± 0.9; P = 0.02). There was moderate inverse correlation between level of HScTnT and eGFR in patients with ACS and CKD (r = -0.5; P value =0.02). Nineteen patients (63.3%) patients had no complications, five patients (16.7%) was complicated with heart failure, three patients (10%) had arrhythmias (atrial fibrillation, ventricular tachycardia, 2nd-degree heart block), and three patients (10%) were arrested and died. Twenty-seven patients (90%) were improved, but death occurred in three patients (10%); two with ventricular arrhythmia and one patient had complete heart block. 
CONCLUSION
There is an adverse relation between the level of highly sensitive troponin T and estimated glomerular filtration rate i.e the less eGFR in CKD patient, the more level of highly sensitive troponin T and There is a direct relation between the higher level of highly sensitive troponin T and mortality and morbidity rates in patients with ACS and CKD.
The specificity of the highly sensitive troponin T decreases with the decreased estimated GFR in ACS and CKD patients resulting in higher level of highly sensitive troponin T required for the diagnosis of NSTE-ACS. For cutoff point of 0.041, ng/ml of HScTnT (the highly sensitive Troponin T) has 90% sensitivity and 52% specificity for the diagnosis of ACS in CKD patients.
